NPCE – neuropace, inc. (US:NASDAQ)
Stock Stats
News
NeuroPace to Present at the 43rd Annual J.P. Morgan Healthcare Conference
NeuroPace, Inc. (NASDAQ: NPCE) had its price target raised by analysts at JPMorgan Chase & Co. from $9.00 to $14.00. They now have an "overweight" rating on the stock.
NeuroPace to Host Investor Day on January 28th in New York City
NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting [Yahoo! Finance]
NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting
Form SC 13G/A NeuroPace Inc Filed by: ORBIMED ADVISORS LLC
Form SC 13G/A NeuroPace Inc Filed by: Soleus Private Equity Fund I, L.P.
Form 10-Q NeuroPace Inc For: Sep 30
Form 8-K NeuroPace Inc For: Nov 12
Form SCHEDULE 13G NeuroPace Inc Filed by: Kent Lake PR LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.